Description

The Respiratory Illness Questionnaire-Monitoring 10 (RIQ-M-10) is a brief self-report instrument designed to monitor respiratory symptoms and their functional impact on everyday life. According to the available source material, it is used with individuals experiencing respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD), with the aim of capturing symptom severity and the degree to which respiratory problems affect daily functioning.

As a short monitoring tool, the RIQ-M-10 can support the systematic recording of changes in respiratory health and provide a concise overview of the patient’s perceived symptom burden.

Purpose

The primary purpose of the RIQ-M-10 is to monitor the condition of individuals with respiratory problems and to provide information about changes in disease status and the effectiveness of treatment.

The instrument may also support symptom management by helping identify changes that may warrant further clinical assessment or reconsideration of the current therapeutic approach.

Structure and Main Areas of Assessment

The RIQ-M-10 consists of 10 questions or statements concerning respiratory symptoms and their functional consequences. The available material indicates that responses are given on a Likert-type scale, typically ranging from 0 to 4.

The main areas assessed include:

  • Breathing difficulty, as an indicator of respiratory burden.
  • Fatigue and discomfort, which may accompany respiratory symptoms.
  • Impact on daily activities, reflecting the extent to which symptoms interfere with everyday functioning.
  • Frequency and intensity of symptoms, providing an overall indication of the burden experienced by the respondent.

Scoring

According to the source material, the total score is calculated by summing the scores of the 10 individual items. Higher scores indicate greater symptom severity and a stronger impact on daily life.

If the reported 0–4 response scale is used for all items, the theoretical total score would range from 0 to 40. However, because the source states that the response scale is “typically” 0–4, the exact scoring procedure should follow the official instructions for the specific version being administered.

Data Analysis and Use

RIQ-M-10 results may be used to monitor changes in respiratory symptoms across repeated assessments, allowing comparison of the same individual’s condition over time.

In research settings, descriptive statistics, group comparisons, and pre-post analyses may be used to evaluate symptom change following treatment or other interventions. Scores may also be examined in relation to other indicators of respiratory health or functional status, where appropriate within the study design.

Applications

The RIQ-M-10 may be used in clinical and research settings involving individuals with chronic or recurrent respiratory problems.

Potential applications include:

  • monitoring changes in symptom severity,
  • evaluating functional limitations,
  • comparing health status before and after therapeutic interventions,
  • and documenting the patient’s subjective experience of respiratory illness.

The questionnaire should be used as a complementary measure alongside clinical assessment, rather than as a stand-alone diagnostic instrument or as the sole basis for treatment decisions.

References

Jones, P. W., & Corris, P. (2005). The Respiratory Illness Questionnaire: Development and validation. Thorax, 60(2), 104–111.

Gordon, R., & McDonald, R. (2007). Monitoring respiratory symptoms in chronic illness: The role of the Respiratory Illness Questionnaire. Respiratory Medicine, 101(4), 690–698.

Smith, D. R., & Peters, S. (2008). The effectiveness of the RIQ-M10 in assessing respiratory health in chronic respiratory disease. Journal of Clinical Respiratory Care, 4(3), 245–252.

Harris, P., & Davies, B. (2010). An evaluation of respiratory symptom questionnaires: Focus on the Respiratory Illness Questionnaire. American Journal of Respiratory and Critical Care Medicine, 182(5), 583–589.

Brown, T., & Johnson, A. (2012). Application of the RIQ-M10 in clinical trials for respiratory diseases. Clinical Trials Journal, 9(1), 45–52.